Especially, Cath-B has been suggested to play an essential role in TNF-mediated apoptosis (Leist and Jaattela, 2001), and has been proposed to represent a therapeutical target in cancer therapy of tumours with elevated levels of cysteine proteases (Foghsgaard et al, 2001). This evidence concerns the gene CTSB and cancer.